HOME › DRUGS › VORTIOXETINE HYDROBROMIDE
ACTIVE SUBSTANCE / INN

VORTIOXETINE HYDROBROMIDE

Brand name(s): TRINTELLIX, VORTIOXETINE HYDROBROMIDE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA204447
ANDA211146
ACTIVE SUBSTANCE
Vortioxetine Hydrobromide
REGULATORS
FDA
SPONSORS / MAH
MSN LABORATORIES PRIVATE LTD, TAKEDA PHARMS USA, ZYDUS PHARMS
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TRINTELLIXNDA204447TAKEDA PHARMS USAPrescription
TRINTELLIXNDA204447TAKEDA PHARMS USADiscontinued
VORTIOXETINE HYDROBROMIDEANDA211146ZYDUS PHARMSDiscontinued
VORTIOXETINE HYDROBROMIDEANDA211101MSN LABORATORIES PRIVATE LTDNone (Tentative Approval)

FULL INTELLIGENCE ON VORTIOXETINE HYDROBROMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →